HuagongsheHuagongshe Chemistry Print Report · For research reference only
Imidazole → HCID 20190090, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | Diethyl Ether | HCID 3283 | — |
| Reactant | Hydroxyethyl imidazolidinone | HCID 77290 | — |
| Reactant | tert-Butyldiphenylchlorosilane | HCID 94078 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 20190090 | HCID 20190090 | — |
Reaction Steps
A solution of 1-(2-hydroxyethyl)-2-oxoimidazolidine (13 g) in dimethylformamide (50 ml) containing imidazole (7.5 g) was treated with t-butylchlorodiphenylsilane (28.6 ml) and the clear solution stirred for 3 hours at ambient temperature. The white suspension formed was dissolved in water (200 ml) and ethyl acetate (500 ml). The aqueous phase was re-extracted with ethyl acetate (100 ml) and the combined organic phases were washed with 3×100 ml portions of water, 1×100 ml brine, dried and evaporated to give a solid. Trituration of the solid with diethyl ether (100 ml) afforded the title compound as a white solid, (33.7 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04684641 |
| Source dataset | uspto-grants-1987_08 |
| ORD ID | ord-2145a2297f49479d9a15bdbfa4ad4a3f |
| Source note | uspto-grants-1987_08 |